Anticholinergic effects in older adults. Weighing the risk-benefit ratio.
Pollock
Bruce G
BG
Academic Division of Geriatrics and Neuropsychology, University of Pittsburgh, PA, USA.
D000368:Aged; D018680:Cholinergic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods* / Q000451:nursing; D004359:Drug Therapy, Combination; D015577:Geriatric Assessment / Q000379:methods*; D005851:Geriatric Nursing / Q000379:methods; D006801:Humans; D008134:Long-Term Care / Q000458:organization & administration; D009730:Nursing Assessment / Q000379:methods; D010348:Patient Care Team / Q000458:organization & administration; D018579:Patient Selection; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
D018680:Cholinergic Antagonists